Sources | Names Used |
---|---|
GDSC1000 | KIN001-102 |
PharmacoGx | KIN001-102 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TAF6L | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
mRNA | SMARCD2 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | AKAP9 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0004 |
mRNA | CMAS | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
mRNA | RFTN1 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | SP100 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
mRNA | COTL1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
mRNA | TGM2 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
mRNA | CDH18 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
mRNA | KIF21B | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0004 |